Sign up
Pharma Capital

Widecells makes move into North Africa, Middle East and Asia-Pacific

Joao Andrade, chief executive of Widecells Group PLC (LON:WDC), tells Proactive they're in the process of inking a deal worth an initial £255,000 that will take the group's stem cell services into the Middle East, North Africa and Asia-Pacific regions.

Andrade says they're aiming to have a formal agreement with Gulf-based White Apex General Trading in place by the end of the month.

 

View full WDC profile

WideCells Group Timeline

Newswire

WideCells expands its reach to Spain

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.